#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Craniopharyngioma Cortical dysplasia Leiomyosarcoma recurrent Neuropathic arthropathy Congenital myopathy Choroidal dystrophy Myotonia Mixed-type liposarcoma Sexually transmitted disease Cystic fibrosis gastrointestinal disease Haemophilia A with anti factor VIII IgA nephropathy Marginal zone lymphoma Antithrombin III deficiency Deafness bilateral More trials…

    Learn about Rare Diseases

    Hypereosinophilic syndrome – Basic Information Burkitt’s lymphoma – Trials in Disease IgA nephropathy – Treatment Mucopolysaccharidosis – Diagnostics Advanced systemic mastocytosis – Treatment Congenital nephrogenic diabetes insipidus – Diagnostics Niemann-Pick disease – Diagnostics Isodicentric chromosome 15 syndrome – Basic Information Adrenocortical carcinoma – Basic Information Congenital hypotransferrinaemia – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Vinblastine Sulfate Peginterferon Beta-1A Erythromycin Lactobionate Mirabegron Folinic Acid Acetic Acid, Glacial Padeliporfin Blu-222 Atrasentan Hydrochloride Calcium Oxybate HAFNIUM OXIDE Omp11 Octreotide Acetate Vamorolone Ag13909 Incb099280 Napabucasin Midostaurin Betaine Citrate Dasiglucagon More therapies…

    Learn about Your Condition

    Retroperitoneal fibrosis Premature rupture of membranes Cystic fibrosis Acromegaly Bacterial infection Diverticulitis Muscular dystrophy CDKL5 deficiency disorder Femoral hernia Large cell lung cancer stage 0 Cushing's syndrome Malignant melanoma Congenital aplastic anaemia Cold urticaria External cephalic version More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Mental Disorders

  • Study on Esketamine and Propofol for Anesthesia in Electroconvulsive Therapy for Patients with Major Depression

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Major depression
    Investigated Drugs:
    • Esketamine Hydrochloride
    • Methohexital Sodium
    • Propofol
    Austria

  • Study of Methylone Treatment for Adults with Post-Traumatic Stress Disorder (PTSD)

    Not recruiting

    1 1
    Investigated Diseases:
    • Post-traumatic stress disorder
    Investigated Drugs:
    • Methylone
    Ireland

  • Study on the Effects of Psilocybin (COMP360) for Adults with Treatment-Resistant Depression

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Psilocybine
    Czechia Denmark France Germany Ireland The Netherlands +3

  • Study on Psilocybin for Patients with Alcohol Use Disorder and Depression Symptoms

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Alcohol use disorder
    Investigated Drugs:
    • Psilocybine
    France

  • Study on the Long-term Use of Pramipexole for Patients with Anhedonic Depression

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Pramipexole
    Sweden

  • Study on Semaglutide’s Effect on Reducing Alcohol Intake in Patients with Alcohol Use Disorder and Obesity

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Alcohol use disorder
    Investigated Drugs:
    • Saline
    • Semaglutide
    Denmark
Previous Page
1 … 36 37 38 39 40
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!